State Street’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.98B | Buy |
98,564,914
+584,476
| +0.6% | +$34.1M | 0.21% | 84 |
|
|
2025
Q4 | $5.29B | Buy |
97,980,438
+1,385,206
| +1% | +$66.6M | 0.18% | 100 |
|
|
2025
Q3 | $4.36B | Buy |
96,595,232
+1,855,238
| +2% | +$86.6M | 0.15% | 114 |
|
|
2025
Q2 | $4.39B | Sell |
94,739,994
-94,484
| -0.1% | -$4.64M | 0.16% | 114 |
|
|
2025
Q1 | $5.78B | Sell |
94,834,478
-310,267
| -0.3% | -$18.1M | 0.24% | 80 |
|
|
2024
Q4 | $5.38B | Buy |
95,144,745
+2,248,165
| +2% | +$126M | 0.21% | 84 |
|
|
2024
Q3 | $4.81B | Buy |
92,896,580
+1,451,214
| +2% | +$68.1M | 0.2% | 95 |
|
|
2024
Q2 | $3.8B | Sell |
91,445,366
-125,744
| -0.1% | -$5.63M | 0.17% | 113 |
|
|
2024
Q1 | $4.97B | Buy |
91,571,110
+2,124,904
| +2% | +$108M | 0.22% | 85 |
|
|
2023
Q4 | $4.59B | Sell |
89,446,206
-28,038
| -0% | -$1.47M | 0.22% | 82 |
|
|
2023
Q3 | $5.19B | Sell |
89,474,244
-3,096,044
| -3% | -$190M | 0.29% | 63 |
|
|
2023
Q2 | $5.92B | Buy |
92,570,288
+858,922
| +0.9% | +$57.6M | 0.31% | 60 |
|
|
2023
Q1 | $6.36B | Sell |
91,711,366
-1,038,635
| -1% | -$73.3M | 0.36% | 53 |
|
|
2022
Q4 | $6.67B | Buy |
92,750,001
+424,103
| +0.5% | +$32M | 0.39% | 48 |
|
|
2022
Q3 | $6.56B | Sell |
92,325,898
-602,471
| -0.6% | -$43.7M | 0.42% | 42 |
|
|
2022
Q2 | $7.2B | Sell |
92,928,369
-1,502,652
| -2% | -$114M | 0.43% | 41 |
|
|
2022
Q1 | $6.95B | Sell |
94,431,021
-214,951
| -0.2% | -$14.4M | 0.34% | 57 |
|
|
2021
Q4 | $5.9B | Buy |
94,645,972
+2,020,678
| +2% | +$119M | 0.28% | 69 |
|
|
2021
Q3 | $5.53B | Buy |
92,625,294
+479,946
| +0.5% | +$31.6M | 0.29% | 66 |
|
|
2021
Q2 | $6.16B | Buy |
92,145,348
+1,196,435
| +1% | +$78M | 0.32% | 61 |
|
|
2021
Q1 | $5.79B | Sell |
90,948,913
-3,214,972
| -3% | -$200M | 0.33% | 66 |
|
|
2020
Q4 | $5.89B | Sell |
94,163,885
-3,327,247
| -3% | -$205M | 0.36% | 56 |
|
|
2020
Q3 | $5.88B | Sell |
97,491,132
-1,587,880
| -2% | -$95.6M | 0.4% | 52 |
|
|
2020
Q2 | $5.83B | Sell |
99,079,012
-1,773,560
| -2% | -$106M | 0.42% | 47 |
|
|
2020
Q1 | $5.62B | Buy |
100,852,572
+1,023,441
| +1% | +$62.6M | 0.49% | 40 |
|
|
2019
Q4 | $6.41B | Buy |
99,829,131
+31,222,918
| +46% | +$1.79B | 0.44% | 42 |
|
|
2019
Q3 | $3.48B | Sell |
68,606,213
-248,927
| -0.4% | -$11.7M | 0.26% | 79 |
|
|
2019
Q2 | $3.12B | Sell |
68,855,140
-58,041
| -0.1% | -$2.7M | 0.23% | 88 |
|
|
2019
Q1 | $3.29B | Buy |
68,913,181
+2,978,884
| +5% | +$148M | 0.26% | 79 |
|
|
2018
Q4 | $3.43B | Buy |
65,934,297
+1,373,108
| +2% | +$73.8M | 0.31% | 68 |
|
|
2018
Q3 | $4.01B | Buy |
64,561,189
+3,062,352
| +5% | +$182M | 0.31% | 67 |
|
|
2018
Q2 | $3.4B | Sell |
61,498,837
-1,395,761
| -2% | -$75.4M | 0.28% | 70 |
|
|
2018
Q1 | $3.98B | Sell |
62,894,598
-3,129,320
| -5% | -$201M | 0.34% | 58 |
|
|
2017
Q4 | $4.05B | Buy |
66,023,918
+466,971
| +0.7% | +$29.2M | 0.33% | 58 |
|
|
2017
Q3 | $4.18B | Sell |
65,556,947
-2,163,513
| -3% | -$126M | 0.36% | 53 |
|
|
2017
Q2 | $3.77B | Sell |
67,720,460
-1,173,319
| -2% | -$63.8M | 0.33% | 55 |
|
|
2017
Q1 | $3.75B | Buy |
68,893,779
+1,223,457
| +2% | +$67.1M | 0.33% | 55 |
|
|
2016
Q4 | $3.95B | Buy |
67,670,322
+2,470,257
| +4% | +$135M | 0.37% | 51 |
|
|
2016
Q3 | $3.52B | Buy |
65,200,065
+1,207,114
| +2% | +$77.5M | 0.35% | 54 |
|
|
2016
Q2 | $4.71B | Sell |
63,992,951
-427,666
| -0.7% | -$30.2M | 0.51% | 41 |
|
|
2016
Q1 | $4.12B | Sell |
64,420,617
-991,536
| -2% | -$62.5M | 0.44% | 47 |
|
|
2015
Q4 | $4.5B | Buy |
65,412,153
+269,422
| +0.4% | +$17.8M | 0.49% | 40 |
|
|
2015
Q3 | $3.86B | Sell |
65,142,731
-760,764
| -1% | -$48.3M | 0.45% | 44 |
|
|
2015
Q2 | $4.39B | Sell |
65,903,495
-2,588,740
| -4% | -$171M | 0.47% | 45 |
|
|
2015
Q1 | $4.42B | Sell |
68,492,235
-1,738,007
| -2% | -$109M | 0.45% | 49 |
|
|
2014
Q4 | $4.15B | Buy |
70,230,242
+2,579,191
| +4% | +$145M | 0.41% | 52 |
|
|
2014
Q3 | $3.46B | Buy |
67,651,051
+1,215,011
| +2% | +$60.7M | 0.37% | 53 |
|
|
2014
Q2 | $3.22B | Buy |
66,436,040
+1,215,302
| +2% | +$59.9M | 0.35% | 56 |
|
|
2014
Q1 | $3.39B | Sell |
65,220,738
-2,240,920
| -3% | -$119M | 0.39% | 53 |
|
|
2013
Q4 | $3.59B | Buy |
67,461,658
+771,467
| +1% | +$39.3M | 0.4% | 50 |
|
|
2013
Q3 | $3.09B | Sell |
66,690,191
-1,521,354
| -2% | -$66.8M | 0.38% | 51 |
|
|
2013
Q2 | $3.05B | Buy |
+68,211,545
| New | +$2.96B | 0.4% | 49 |
|
Other funds holding BMY
VCM
VPM
State Street's BMY Position: Q1 2026 in Review
State Street increased its Bristol-Myers Squibb (BMY) stake by 0.6% in Q1 2026, buying an estimated $34.1M and bringing the position to 98,564,914 shares worth $5.98B. The position accounts for 0.21% of the portfolio, ranked #84.
State Street first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.2B in Q2 2022. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- State Street held 98,564,914 shares of Bristol-Myers Squibb worth $5.98B as of Q1 2026.
- State Street bought 584,476 Bristol-Myers Squibb shares in Q1 2026, an estimated $34.1M.
- Bristol-Myers Squibb made up 0.21% of State Street's portfolio in Q1 2026, its #84 holding.
- State Street first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- State Street's Bristol-Myers Squibb position peaked at $7.2B in Q2 2022.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.